InnovAge Holding Corp. Cost, Overhead
InnovAge Holding Corp. (INNV) reported Cost, Overhead of $45.52 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-06.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSoldOverhead · last filed 2025-05-06
- InnovAge Holding Corp. cost, overhead for the quarter ending 2025-03-31 was $45.52M, a 31.07% increase year-over-year.
- InnovAge Holding Corp. cost, overhead for the quarter ending 2024-12-31 was $35.81M, a 15.11% increase year-over-year.
- InnovAge Holding Corp. cost, overhead for the quarter ending 2024-09-30 was $34.03M, a 0.87% decline year-over-year.
- InnovAge Holding Corp. cost, overhead for the quarter ending 2024-06-30 was $36.13M, a 2.89% increase year-over-year.
- InnovAge Holding Corp. cost, overhead for fiscal 2024 was $136.29M, a 0.76% increase from fiscal 2023.
- InnovAge Holding Corp. cost, overhead for fiscal 2023 was $135.26M, a 7.48% increase from fiscal 2022.
- InnovAge Holding Corp. cost, overhead for fiscal 2022 was $125.85M.
| Period end | Cost, Overhead 3 month | Cost, Overhead 6 month | Cost, Overhead 9 month | Cost, Overhead 12 month |
|---|---|---|---|---|
| 2025-03-31 | $45.52M 10-Q · filed 2025-05-06 | $81.33M derived: sum of 2 quarters · filed 2025-05-06 | $115.35M 10-Q · filed 2025-05-06 | $151.49M derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | $35.81M 10-Q · filed 2025-02-04 | $69.83M 10-Q · filed 2025-02-04 | $105.97M derived: sum of 3 quarters · filed 2025-02-04 | $140.69M derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-09-30 | $34.03M 10-Q · filed 2024-11-05 | $70.16M derived: sum of 2 quarters · filed 2024-11-05 | $104.89M derived: sum of 3 quarters · filed 2025-05-06 | $136.00M derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-06-30 | $36.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $70.86M derived: sum of 2 quarters · filed 2025-05-06 | $101.97M derived: sum of 3 quarters · filed 2025-05-06 | $136.29M 10-K · filed 2024-09-10 |
| 2024-03-31 | $34.73M 10-Q · filed 2025-05-06 | $65.84M derived: sum of 2 quarters · filed 2025-05-06 | $100.16M 10-Q · filed 2025-05-06 | $135.28M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $31.11M 10-Q · filed 2025-02-04 | $65.43M 10-Q · filed 2025-02-04 | $100.55M derived: sum of 3 quarters · filed 2025-02-04 | $133.51M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $34.33M 10-Q · filed 2024-11-05 | $69.44M derived: sum of 2 quarters · filed 2024-11-05 | $102.40M derived: sum of 3 quarters · filed 2024-11-05 | $135.00M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $35.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $68.08M derived: sum of 2 quarters · filed 2024-09-10 | $100.67M derived: sum of 3 quarters · filed 2024-09-10 | $135.26M 10-K · filed 2024-09-10 |
| 2023-03-31 | $32.96M 10-Q · filed 2024-05-07 | $65.55M derived: sum of 2 quarters · filed 2024-05-07 | $100.15M 10-Q · filed 2024-05-07 | $132.64M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $32.59M 10-Q · filed 2024-02-06 | $67.19M 10-Q · filed 2024-02-06 | $99.67M derived: sum of 3 quarters · filed 2024-02-06 | $130.50M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $34.59M 10-Q · filed 2023-11-07 | $67.08M derived: sum of 2 quarters · filed 2023-11-07 | $97.91M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | $32.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $63.31M derived: sum of 2 quarters · filed 2023-09-12 | $125.85M 10-K · filed 2023-09-12 | |
| 2022-03-31 | $30.83M 10-Q · filed 2023-05-09 | $93.36M 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |